Author

N. Lawrence

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Organism:bacteria (other)· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. J. Craik· 3 shared A. S. Amiss· 2 shared B. J. Currie· 2 shared J. R. Webb· 2 shared S. T. Henriques· 2 shared A. H. Benfield· 1 shared F. N. Bufi· 1 shared F. Vernen· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

D. J. Craik

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Membrane-active peptides escape drug-resistance in cancer

A. H. Benfield, F. Vernen, R. S. E. Young, F. N. Bufi, H. Hammerlindl, D. J. Craik, H. Schaider, N. Lawrence, S. J. Blanksby, S. T. Henriques

This study shows membrane-active peptides can kill drug-resistant melanoma cells without inducing resistance, suggesting their potential as therapeutic agents.

bioRxiv · Oct 27, 2022 · PreprintCancer Biology

Modified defence peptides from horseshoe crab target and kill bacteria inside host cells

A. S. Amiss, J. B. von Pein, J. R. Webb, N. D. Condon, P. J. Harvey, M.-D. Phan, M. A. Schembri, B. J. Currie, M. J. Sweet, D. J. Craik, R. Kapetanovic, S. T. Henriques, N. Lawrence

This study identifies modified antimicrobial peptides from horseshoe crabs that effectively kill bacteria, including UPEC, both extracellularly and intracellularly, with reduced toxicity to mammalian cells.

bioRxiv · Jun 27, 2021Microbiology

Drug susceptibility profiling of Australian Burkholderia species as models for developing melioidosis therapeutics

A. S. Amiss, J. R. Webb, M. Mayo, B. J. Currie, D. J. Craik, S. Troeira Henriques, N. Lawrence

The paper profiles drug susceptibility of Australian Burkholderia species to identify models for developing melioidosis therapeutics, finding high similarity in susceptibility profiles between B. pseudomallei and less pathogenic species.

The American Journal of Tropical Medicine and Hygiene · Nov 4, 2020Peer-reviewedMicrobiology